Study guide

12.4 Emerging Technologies and Data Governance

Certified Professional in Healthcare Information and Management Systems CPHIMS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility Pathways and Qualifying Experience 1.3 Scoring, Retakes, and Recertification 1.4 Domain-Weighted Study Strategy

2 Healthcare Organizations and Relationships

2.1 Hospitals, Clinics, Ambulatory, and Community Organizations 2.2 Payers, Regulators, Research, and Academic Organizations 2.3 Interrelationships, HIE, and Continuity of Care 2.4 HIT Professional Roles and Organizational Structures

3 Policy, Accreditation, and Care Trends

3.1 Privacy and Security Law: HIPAA and HITECH 3.2 Interoperability Policy and Information Blocking 3.3 Accreditation, Patient Rights, and Environments of Care 3.4 Telehealth, Portals, Wearables, and Population Health

4 Healthcare Applications

4.1 Clinical Applications 4.2 Administrative and Financial Applications 4.3 Consumer-Facing Applications 4.4 Business Intelligence Applications

5 Technology Infrastructure

5.1 Networks and Communications 5.2 Data Integration Architectures 5.3 Infrastructure Privacy and Security 5.4 Cloud, Devices, and Identity Infrastructure

6 Clinical Language, Terminologies, and Metrics

6.1 Clinical Vocabulary 6.2 Healthcare IT Vocabulary 6.3 Clinical Terminologies: SNOMED CT, LOINC, RxNorm, and ICD 6.4 Clinical Metrics and Operational Measures

7 Clinical Effectiveness and Workflows

7.1 System Functionality for Clinical Effectiveness 7.2 Workflows, Order Sets, and Pathways 7.3 Safety, Quality, and Clinical Informatics Design

8 Informatics Analytics

8.1 Analytics Tools, Reports, Tables, and Graphs 8.2 Interpreting Clinical and Operational Outcomes 8.3 Predictive Models in Care and Operations

9 Clinical Content and Decision Support

9.1 Clinical Content Lifecycle 9.2 Clinical Decision Support Types and Design 9.3 CDS Governance, Alert Management, and Knowledge Maintenance

10 Analysis, SDLC, and Improvement Methods

10.1 Systems Development Life Cycle 10.2 Project Management: Needs, Gap, and Requirements 10.3 Process Improvement: DMAIC and PDCA 10.4 Process Maps, Flow Diagrams, and Gap Analysis

11 Analysis: Solutions and the Business Case

11.1 Disparate Data Sets and Alternate Solutions 11.2 Strategic Alignment and Cost-Benefit Analysis 11.3 Proposals, RFPs, RFIs, SLAs, SOWs, and NDAs

12 Systems Design

12.1 Interoperability of Software, Hardware, Networks, and Devices 12.2 Design Compliance and Incorporating Industry Trends 12.3 Business Continuity and Disaster Recovery Design 12.4 Emerging Technologies and Data Governance

13 Selection, Implementation, Support, and Maintenance

13.1 Solution Selection Activities 13.2 Technical Change Management, Training, and Support 13.3 Implementation: Scope, Schedule, Budget, and Quality 13.4 Maintenance, Operations, and Problem-Trend Analysis

14 Testing, Evaluation, Privacy, and Security

14.1 Testing Methodology and Internal Controls 14.2 Validation and Benefits Realization 14.3 Privacy and Security Policies, Access, and Safeguards 14.4 Vulnerabilities, Roles, Data Controls, and Ongoing Validation

15 Strategy and IT Planning

15.1 Contributing to Organizational Strategic Planning 15.2 Assessing the Organizational Environment 15.3 Forecasting Technical and Information Needs 15.4 IT Strategic Plans and Departmental Objectives

16 Performance, Policy, Ethics, and Analytics

16.1 Evaluating Performance Against SLAs and Indicators 16.2 User Satisfaction and Service Effectiveness 16.3 Policies, Legal Compliance, and Ethical Principles 16.4 Comparative Analytics and Presenting Recommendations

17 Communication, Stakeholders, and Change

17.1 Promoting Stakeholder Understanding of IT Opportunities and Constraints 17.2 Business Communications and Consultative Technology Services 17.3 Facilitating Groups, Consensus, and Conflict Resolution 17.4 Organizational Change Management and Stakeholder Relationships

18 People, Projects, Vendors, and Finance

18.1 HIT Roles, Job Descriptions, and Staff Competency 18.2 Educational Strategies and Maintaining IT Competencies 18.3 Managing Projects and Portfolios 18.4 Vendor Contracts, Budgets, and Risk Management

12.4 Emerging Technologies and Data Governance

Key Takeaways Explain This Topic AI

Evaluate emerging technology against a stated strategy, a measure, interoperability, evidence, privacy, safety and equity, workforce, TCO/exit, and governance. A vendor demo is a scan input, not an approval.

Pilots are time-boxed, criteria-first, and killable. Auto-renewing a pilot into an enterprise standard is a governance failure.

Data ownership is accountability for purpose, quality bar, access, and retention. Stewardship is the operational care of definitions and issues. IT is often the custodian, not the owner of clinical meaning.

Data quality is fitness for use: accuracy, completeness, timeliness, uniqueness, validity, consistency, and integrity. Duplicate MPI and late ADT are quality defects, not “interface noise.”

Master data are the shared nouns—patient, provider, location, organization, and catalogs. A new app that creates a second patient identity is a master-data incident, not innovation.

Last updated: August 2026

12.4 Emerging Technologies and Data Governance

Quick Answer: Emerging technology is allowed only when it advances a stated strategy at an acceptable risk. Data governance —ownership, stewardship, quality, and master data—is how you keep that technology from creating a second chart, a shadow AI corpus, or an unowned feed. No owner, no production.

Tasks B.5 and B.6 close the design chapter. B.5 asks whether you can evaluate a new tool without becoming the vendor’s implementation arm. B.6 asks who owns the data that tool will create or consume. Together they prevent the pattern CPHIMS punishes: a pilot that bypasses interoperability design (12.1), compliance intake (12.2), and the RPO you just funded (12.3).

Use CPHIMS practice questions for “approve, park, or kill” stems. RHIA is the deeper HIM credential for record integrity and master patient index practice; CPHIMS still expects you to place ownership and master data in the architecture.

Evaluating emerging technology against strategy

“Emerging” is not a synonym for illegal, and it is not a synonym for mandatory. The design question is: does this technology advance a written organizational objective at a risk the board would recognize?

Lens Questions to force into the file Fail if

Strategy fit Which objective, service line, or safety goal? Who asked? Solution looking for a problem; innovation theater

  • Problem and measure What process fails today? What metric will move? No baseline, no outcome owner
  • Interoperability Standards, identity, export, IHE/FHIR/v2 path (12.1) Screenshot medicine; trapped data
  • Evidence Intended use, local or peer validation Marketing case study only
  • Privacy and security BAA, minimum necessary, where training data go Shadow AI on real ePHI
  • Safety and equity Failure modes, bias, who is excluded from the pilot Easiest clinic only; no harm review
  • Workforce Who operates it on Tuesday night? Another inbox with no FTE
  • TCO and exit License, integration, de-install, data return or destroy Hostage data; no exit
  • Governance Owner, steward, retention, audit (this section) “The vendor owns the data”

Pilot design is part of B.5. Write success criteria and kill criteria before go-live. Time-box the pilot. Do not auto-renew into an enterprise standard. Prefer non-production or tightly limited production with a rollback. A successful pilot still re-enters the 12.2 compliance gate before scale.

Examples in CPHIMS language:

Ambient AI scribe. Strategy = documentation burden. Require a BAA, retention rules, identity of the author, sampling for accuracy, and a plan when the note is wrong. “It writes faster” is not a measure unless you also watch addenda and safety.

Consumer wearable or RPM feed. Strategy = a named chronic-care outcome. Require identity binding, device pedigree, missingness rules, and inbox ownership (Chapter 3). A firehose of steps is not a care program.

SMART on FHIR third-party app. Strategy = a specific workflow gap. Require launch context, scopes, write-back rules, and a steward for any problem or med it creates.

Blockchain for “the longitudinal record.” Usually fails strategy-fit unless you have a real multi-party provenance problem that existing HIE, TEFCA, and audit controls do not address. Hype is a scan input.

Do not let a model card replace a data-use decision. Do not let a sandbox API key become a production extract.

Data governance vocabulary — keep the roles distinct

Data ownership is accountability for a domain: purpose of use, quality bar, access policy, and retention. The owner is usually a clinical or operational executive (CMIO for problems and orders, HIM for the legal record, revenue cycle for claims identity)—not the application analyst who clicks the build.

Data stewardship is the operational care of definitions, code tables, issue queues, and day-to-day quality. Stewards investigate duplicates, accept or reject a definition change, and escalate to the owner when the bar cannot be met.

Data custodianship is where IT usually sits: platforms, backups, access mechanics, and pipeline reliability. Custodians do not get to redefine “allergy” because a table is inconvenient.

Data quality is fitness for a stated use, along dimensions you should be able to name:

  • Dimension Meaning HIT example
  • Accuracy Matches the real world Allergy listed is the allergy the patient has
  • Completeness Required elements present Problem without onset when the measure needs onset
  • Timeliness Fresh enough for the use ADT discharge posted six hours late
  • Uniqueness One real-world entity, one surviving record Duplicate MPI
  • Validity Conforms to rules and value sets Gender or race code not in the allowed set
  • Consistency Same fact agrees across systems Two dates of birth after an overlay
  • Integrity Not improperly altered Unsigned change to a result
  • Duplicate rate, overlay rate, and interface-error age are quality SLAs , not “engine noise.”

Master data are the slow-changing nouns the enterprise must share: patient, provider, location/unit, organization , plus reference catalogs (formulary, lab dictionary). Master data are not a warehouse fact table. If the patient or location is wrong, every interface in 12.1 is wrong. Reference data are the allowed values and code systems. Metadata and lineage say what a field means and where it came from—mandatory when AI or quality reporting consumes the field.

MPI/EMPI is a master-data program with survivorship rules, not a nightly job nobody owns. Golden-record decisions need a steward and an appeal path, because a bad merge is a wrong-patient event.

Operating model

A data-governance council with clinical, HIM, quality, revenue, and IS seats—not an IT CAB alone (same spirit as CDS governance in Chapter 9).

Named domain owners and stewards, published in a RACI, not implied.

Change control on catalogs and master data, with versions you can reconstruct.

Classification (public / internal / confidential / ePHI) that drives API and emerging-tool design.

Quality reports on a standing agenda: MPI duplicates, overlays, feed lag, completeness of required USCDI or measure elements.

An exit clause in every emerging-tech contract: return or destroy ePHI, revoke keys, and document lineage.

Where emerging tech and governance collide

A SMART app writes problems and no steward owns the problem list.

An AI vendor trains on identifiable notes without a use decision from the data owner.

A marketing “engagement platform” mints a second patient identity and never talks to the EMPI.

A device cloud becomes the de facto system of record for vitals, with a worse RPO than the EHR.

A “de-identified” extract is still re-identifiable and leaves without a classification check.

Design rule: no production emerging technology without a named data owner, a quality bar, master-data alignment, a 12.2 compliance pass, and an exit that returns or destroys ePHI. If you cannot say who owns the data Tuesday morning, you are not ready to evaluate the algorithm.

Study heuristic: relative design risk if this governance gap is left open (illustrative emphasis, not measured rates)

Scenarios and exam traps

Scenario. A vendor offers a free ambient-scribe pilot if the health system “shares notes to improve the model.” Strategy-fit might exist, but B.6 fails until an owner decides purpose of use, a BAA exists, and training on identifiable notes is an explicit, recorded decision—not a click-through.

Scenario. Population-health marketing buys an engagement app that registers patients with email as the only identifier. Treat it as a master-data incident. Bind to the EMPI or do not launch.

Scenario. The application analyst is listed as “owner” of the enterprise problem list because they can edit the data dictionary. Reassign ownership to a clinical executive and keep the analyst as builder or custodian.

Scenario. A pilot succeeds on one clinic’s well-resourced panel and leadership wants system-wide default-on next Monday. Re-enter B.5 evaluation for equity, workforce, and TCO; re-enter B.2 for certification and privacy. A happy clinic is not a scale decision.

Watch these traps:

Treating a demo or hype cycle as strategy alignment.

Letting IT or the vendor “own” clinical meaning.

Confusing stewardship (operations) with ownership (accountability).

Standing up a second identity or catalog and calling it innovation.

Auto-promoting pilots.

Skipping exit and lineage because the algorithm is accurate in a slide deck.

Domain 3 design is now a chain: interoperable layers (B.1), a process that absorbs law and trends (B.2–B.3), BC/DR you can actually run (B.4), and technology that does not outrun its data owners (B.5–B.6). Selection and implementation in Chapter 13 assume this design exists.